Swiss - Delayed Quote CHF
Eli Lilly and Company (LLY.SW)
675.00
0.00
(0.00%)
As of April 22 at 11:56:13 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALVAREZ RALPH Director | Stock Award(Grant) | Apr 21, 2025 | 54,847 |
| DOZIER ERIC Officer | Conversion of Exercise of derivative security | Feb 28, 2025 | 10,173 |
| FYRWALD J. ERIK Director | Stock Award(Grant) | Apr 21, 2025 | 72,839 |
| HEDLEY MARY LYNNE Director | Stock Award(Grant) | Apr 21, 2025 | 2,029 |
| HERNANDEZ EDGARDO President | Conversion of Exercise of derivative security | Feb 28, 2025 | 40,616 |
| LILLY ENDOWMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 3, 2025 | 96,017,000 |
| LUCIANO JUAN R Director | Stock Award(Grant) | Apr 21, 2025 | 16,294 |
| SKOVRONSKY DANIEL M. Officer | Sale | Feb 10, 2025 | 212,276 |
| SULZBERGER GABRIELLE Director | Stock Award(Grant) | Apr 21, 2025 | 2,562 |
| ZAKROWSKI DONALD A Officer | Sale | Mar 13, 2025 | 7,559 |
Related Tickers
RHHBF Roche Holding AG
355.38
0.00%
GRF.MC Grifols, S.A.
8.51
+0.73%
GSK.L GSK plc
1,386.71
-0.52%
NOV.DE Novo Nordisk A/S
53.97
-1.80%
BIIB Biogen Inc.
118.82
-0.58%
AMGN Amgen Inc.
279.26
-0.21%
MRK Merck & Co., Inc.
78.77
-1.35%
NOVO-B.CO Novo Nordisk A/S
403.55
-1.60%
NVO Novo Nordisk A/S
61.45
-1.88%
ABBV AbbVie Inc.
182.25
+1.04%